Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, obesity
To combat some of these symptoms, you should follow a few rules when taking this medication
Both can route GLP-1 receptor agonists through telehealth
For post-GLP-1 patients who have already achieved significant fat loss, these treatments offer limited benefit and may actually accentuate loose skin by removing underlying volume
Optum Rx has introduced a host of tools at the formulary and benefit design levels, to ensure GLP-1 drugs are used responsibly
However, caution must be taken when examining exogenous gut peptide studies, as many times the dose is supraphysiological, and while there may be therapeutic relevance, it may not be an accurate representation of endogenous gut peptide action